PM&R Meeting Abstracts

Official abstracts site for the AAPM&R Annual Assembly and the PM&R Journal.

MENU 
  • Home
  • Meetings Archive
    • AAPM&R Annual Assembly 2022
    • AAPM&R Annual Assembly 2021
    • AAPM&R Annual Assembly 2020
    • AAPM&R Annual Assembly 2019
  • Resources
  • Advanced Search

Focal Extracorporeal Shockwave Therapy Muscle Enhancement in a Patient with Arthrogenic Muscle Inhibition: A Case Report

Marcos R. Henriquez, MD (Rehabilitek, PM&R, Sports Medicine, Santo Domingo, Distrito Nacional); Francisco Bentz, MD, MFR; Isabella Nuñez, MD

Meeting: AAPM&R Annual Assembly 2021

Categories: Musculoskeletal and Sports Medicine (2021)

Session Information

Session Title: AA 2021 Virtual Posters - Musculoskeletal and Sports Medicine

Session Time: None. Available on demand.

Disclosures: Marcos R. Henriquez, MD: No financial relationships or conflicts of interest

Case Diagnosis: Quadriceps arthrogenic muscle inhibition

Case Description: A 42-year-old male patient with a five-week post-surgical right meniscus repair comes to our office with right knee functional limitation, assisted with crutches. He describes that his right knee “gives away” on weight-bearing and refers to difficulty climbing or running downstairs, followed by anterior knee pain. There is edema on his right knee on the physical exam. After several attempts, the patient cannot step up to a 22-cm stool, describing weakness and difficulty. When stepping down with his right leg from the stool, there’s increased femoral adduction, followed by instability and sensation that the “knee is giving away”. We treated our patient with one session of electrohydraulic focal extracorporeal shockwave therapy (F-ESWT) with the following protocol: Right quadriceps: 0.1mJ/mm2, 600 impulses. Right hamstring: 0.1mJ/mm2, 300 impulses. Gluteus medius: 0.1mJ/mm2, 300 impulses. Tibialis anterior: 0.1mJ/mm2, 200.

Setting: PM&R, Sports Medicine, Outpatient ClinicAssessment/

Results: Immediately after the first session of F-ESWT, the patient can step up the 22-cm stool with his right knee without pain and can step down without pain or sensation that the “knee is giving away”. The patient is able to walk without crutches and does not describe pain or weakness.

Discussion: After reviewing current literature, to our knowledge, this is the first case describing the use of focal extracorporeal shockwave therapy in arthrogenic muscle inhibition.

Conclusion: Arthrogenic muscle inhibition surely can prolong a rehabilitation process and lead to functional impairment. The use of focal extracorporeal shockwave therapy could accelerate and meet the patient’s goal.

Level of Evidence: Level V

To cite this abstract in AMA style:

Henriquez MR, Bentz F, Nuñez I. Focal Extracorporeal Shockwave Therapy Muscle Enhancement in a Patient with Arthrogenic Muscle Inhibition: A Case Report [abstract]. PM R. 2021; 13(S1)(suppl 1). https://pmrjabstracts.org/abstract/focal-extracorporeal-shockwave-therapy-muscle-enhancement-in-a-patient-with-arthrogenic-muscle-inhibition-a-case-report/. Accessed May 11, 2025.
  • Tweet
  • Email
  • Print

« Back to AAPM&R Annual Assembly 2021

PM&R Meeting Abstracts - https://pmrjabstracts.org/abstract/focal-extracorporeal-shockwave-therapy-muscle-enhancement-in-a-patient-with-arthrogenic-muscle-inhibition-a-case-report/

Leading the Way. Baltimore, MD & Virtual. October 20-23, 2022. #aapmr22

PM&R Journal

View issues of PM&R on the Wiley Online Library »

American Academy of Physical Medicine and Rehabilitation

Visit the official site for the American Academy of Physical Medicine and Rehabilitation »

AAPM&R Annual Assembly

Visit the official site for the AAPM&R Annual Assembly »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
Wiley